Clinical trials recruiting for Lymphoproliferative Disorders
5
Recruiting trials
18
US states with sites
9
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Atezolizumab | 1 |
| Dabrafenib | 1 |
| Entrectinib | 1 |
| Trametinib | 1 |
| tabelecleucel | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Missouri | 1 |
| New York | 1 |
| North Carolina | 1 |
| Ohio | 1 |
Top cities
Atlanta, Georgia 1Baltimore, Maryland 1Boston, Massachusetts 1Chapel Hill, North Carolina 1Charleston, South Carolina 1Charlotte, North Carolina 1Chicago, Illinois 1Cleveland, Ohio 1Columbus, Ohio 1Dallas, Texas 1
Self-screener
Recruiting trials
- A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
- DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
- DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- Virtual Rehabilitation for Cancer Survivors
Related conditions
Trials recruiting for Lymphoproliferative Disorders often also study these conditions. Each links to its own recruiting-trial list.
Neoplasms by Site 11Neoplasms by Histologic Type 4Melanoma 487Malignant Neoplasm 13Colorectal cancer 1359Solid Tumour 5Pancreatic cancer 870Malignancy 4Lung cancer 2180Haematological Malignancy 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lymphoproliferative Disorders trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.